This is why Viking Therapeutics, Inc. (VKTX) is a Strong Buy on Wall Street
Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the best biotech stocks to buy according to Wall Street analysts. On November 20, H.C.
Viking Therapeutics Inc. (VKTX)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 1,898,342 | $49,888,428 | +118% | 0.01% |
| 2. | Two Sigma Advisors John Overdeck And David Siegel | 1,555,128 | $40,868,764 | +43% | 0.08% |
| 3. | 1,267,800 | $33,317,784 | +16% | 0.01% | |
| 4. | 1,232,600 | $32,392,728 | +56% | 0% | |
| 5. | Tang Capital Management Kevin C. Tang | 870,000 | $22,863,600 | +136% | 0.88% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $24.15 | 1,240 | $29,942.78 | 1,240 | 2025-03-31 | Filing | |
| $24.15 | 1,240 | $29,942.78 | 1,240 | 2025-03-31 | Filing | |
| $2.47 | 45,000 | $111,195.00 | 111,250 | 2022-05-02 | Filing | |
| $5.69 | 20,000 | $113,800.00 | 66,250 | 2021-06-10 | Filing | |
| $9.82 | 9,500 | $93,260.55 | 9,500 | 2018-05-31 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $35.00 | 6,185 | $216,491.70 | 382,467 | 2025-10-28 | Filing | |
| $35.57 | 60,000 | $2,134,278.00 | 30,000 | 2025-10-27 | Filing | |
| $35.01 | 38,989 | $1,364,923.01 | 2,419,109 | 2025-10-28 | Filing | |
| $35.00 | 6,185 | $216,480.57 | 173,592 | 2025-10-28 | Filing | |
| $27.80 | 26,889 | $747,632.51 | 2,388,014 | 2025-07-03 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,999,107 | $262,776,531 | 0% | |
| 2. | 5,790,051 | $152,162,529 | 0.01% | |
| 3. | 5,596,166 | $147,067,246 | 0% | |
| 4. | 4,513,832 | $118,623,505 | 0% | |
| 5. | 3,729,117 | $98,001,218 | 0.01% |
News See All
15 Best Biotech Stocks to Buy According to Wall Street Analysts
The biotech sector has been a disaster for investors over the past five years going by a 14% decline compared to an 86% gain for the S&P 500 over the same period.
Viking Therapeutics (VKTX) VANQUISH-1 Trial Completes Early, H.C. Wainwright Retains Buy Rating
Viking Therapeutics, Inc. (NASDAQ:VKTX) ranks among the best short squeeze stocks to buy right now. On November 20, H.C.
12 Best Short Squeeze Stocks to Buy Right Now
As the year comes to a close, investors are keeping close tabs on the Federal Reserve's impending policy move, given the US shutdown-induced data shortage.
William Blair Reiterates “Buy” Rating on Viking Therapeutics (VKTX) Following New VK2735 Data
On November 6, 2025, Viking Therapeutics Inc.
15 Stocks Set to Explode in 2026
While the market figures out whether artificial intelligence is driving the next bubble or the next industrial revolution, a quiet rotation of capital into the next wave of growth leaders outside Big ...
8 Stocks Jim Cramer Was Asked About
“We keep hearing about how the stock market's valuation has reached excessive levels. And as I said at the top of the show, some segments of the market are overvalued.
Viking Therapeutics, Inc. (NASDAQ:VKTX) Q3 2025 Earnings Call Transcript
Operator: Welcome to the Viking Therapeutics Third Quarter 2025 Financial Results Conference Call.
Viking Therapeutics (VKTX) Receives a Buy from Oppenheimer
Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the best healthcare stocks with the highest upside. Viking Therapeutics, Inc.
9 Best Healthcare Stocks with the Highest Upside
Talking about how people are feeling the impact of the shutdown, Dr.
Hedge Fund Resource Center Billionaire Hedge Funds
